Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced the presentation of new preclinical data for K…
Rates of Physician Attrition From Clinical Practice Have Risen Since 2013 A recent study found that the rate of physician attrition from c…
Dracula Technologies Secures €30M in Series A Round Valence-based Dracula Technologies has announced the successful completion of its Seri…
New Toronto Transit Station to Open A new station serving GO Transit's Kitchener Line and UP Express is set to open in weeks. Metro…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of N…
Requtech Expands into Satcom Infrastructure Requtech, a long-standing antenna design company, has launched a satellite communications (Sat…
World Treadmill Championships to Debut in 2026 The first-ever World Treadmill Championships, dubbed RUN X, will take place over 5km in 202…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, marking the…
Sivers Semiconductors Achieves Solid Q3 Performance Sivers Semiconductors AB has announced its Q3 2025 results, demonstrating sustained pe…
Introduction to Altermagnetism Experiments have only recently confirmed the existence of altermagnetic materials, but they are already gen…
The Glimpse Group Launches IPO/Spin-Off Initiative The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR), a diversified Immersive Technology p…